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Crystal structure of mammalian purple acid phosphatase
Luke W Guddat1*, Alan S McAlpine1, David Hume1, Susan Hamilton1,
John de Jersey1 and Jennifer L Martin2*
Background: Mammalian purple acid phosphatases are highly conserved binu-
clear metal-containing enzymes produced by osteoclasts, the cells that resorb
bone. The enzyme is a target for drug design because there is strong evidence
that it is involved in bone resorption.
Results: The 1.55 Å resolution structure of pig purple acid phosphatase has
been solved by multiple isomorphous replacement. The enzyme comprises
two sandwiched β sheets flanked by α-helical segments. The molecule
shows internal symmetry, with the metal ions bound at the interface between
the two halves.
Conclusions: Despite less than 15% sequence identity, the protein fold resem-
bles that of the catalytic domain of plant purple acid phosphatase and some
serine/threonine protein phosphatases. The active-site regions of the mam-
malian and plant purple acid phosphatases differ significantly, however. The
internal symmetry suggests that the binuclear centre evolved as a result of the
combination of mononuclear ancestors. The structure of the mammalian enzyme
provides a basis for antiosteoporotic drug design.
Introduction
Purple acid phosphatases (PAPs) are a group of nonspecific
phosphomonoesterases, members of which have been char-
acterised from animal, plant and fungal sources (for a recent
review see [1]). The enzymes are distinguished from other
acid phosphatases by their characteristic purple colour in
concentrated solution. The animal enzymes are also distin-
guished from lysosomal and prostatic acid phosphatases by
their resistance to inhibition by L(+)tartrate, and are com-
monly referred to as ‘tartrate-resistant acid phosphatases’
(TRAPs). TRAP activity is the most commonly used histo-
chemical marker for osteoclasts, the cells that resorb bone.
The TRAP gene is expressed at highest levels in these cells
and is required for normal bone resorption. A transgenic
knockout mouse lacking the enzyme is mildly osteopetrotic
and also has defects in endochondral ossification [2]. We
have shown that both pyrophosphate and phosphotyrosine-
containing peptides are excellent substrates for mammalian
PAPs, especially at the low pH of the osteoclastic space [3].
Pyrophosphate is a known inhibitor of bone resorption and
the phosphotyrosine-containing protein osteopontin has
been implicated in the attachment of osteoclasts to bone.
Experiments in vitro have shown that when osteopontin is
partially dephosphorylated by PAP it no longer binds osteo-
clasts [4]. Determination of the structure of mammalian
PAP is therefore important for probing the substrate speci-
ficity of the enzyme and ultimately in designing potent and
selective inhibitors that may prove useful in the treatment
of bone resorptive diseases.
All of the PAPs characterised to date contain a binuclear
metal centre (FeIII–MeII). A charge-transfer interaction
between a tyrosine and the FeIII atom is responsible for
the visible absorption. Mammalian PAPs have been char-
acterised from human [3,5], pig [6], rat [7], mouse [3] and
cow [6]. The enzymes are closely related: all are
monomeric glycoproteins of ~35 kDa with amino acid
sequences exhibiting >80% identity [7–9]. The active
form of mammalian PAP is pink (λmax = 550 nm), and
contains a binuclear FeIII–FeII metal centre in which
the iron atoms are antiferromagnetically coupled [10,11].
Oxidation converts the enzyme to the inactive, purple
FeIII–FeIII form (λmax ~550 nm) [12]. In addition to its
phosphatase activity, the redox-active FeIII–FeII form
of the mammalian enzyme can act as a catalyst of
hydroxyl radical production in a Fenton-like reaction
[5,13], using hydrogen peroxide and a reducing agent
such as superoxide as substrates:
Enz–FeII–FeIII + H2O2 → Enz–FeIII–FeIII + ⋅OH + –OH
Enz–FeIII–FeIII + O2⋅– → Enz–FeII–FeIII + O2
Both osteoclasts and macrophages produce hydroxyl radi-
cals, and whereas the Fenton catalyst has not been identi-
fied in either cell type, PAP is a candidate.
Members of another class of phosphatase, the serine/threo-
nine protein phosphatases that include protein phosphatases
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1 and 2B (calcineurin), also contain binuclear metal centres
and appear to be related structurally to the PAPs [14]. A con-
served sequence motif which encompasses the metal
ligands in the protein phosphatases and the PAPs has been
designated a ‘metalloesterase signature motif’ and has been
identified in a range of other less well characterised phos-
phoesterases that are presumed to contain binuclear metal
centres [15]. These metal-containing phosphatases are in
turn part of a much larger and more diverse family of pro-
teins which contain binuclear metal centres. Functions for
these proteins include oxygen transport and activation,
catalysis of isomerisation, phosphoryl transfer, hydration and
a broad range of hydrolytic reactions [16,17]. 
Until now, the only available structure for a PAP has been
that of the red kidney bean enzyme, determined at 2.65 Å
resolution by Klabunde and colleagues [15,18]. In con-
trast to the monomeric 35 kDa mammalian enzyme, the
plant PAP is a homodimer with subunits of ~55 kDa.
Each subunit of the plant enzyme incorporates a binu-
clear FeIII–ZnII centre. Despite overall low sequence
identity between the plant and animal PAPs (<20%
within the catalytic domains), the amino acid residues
which provide the metal ligands to the iron (Tyr167,
His325 and Asp135) and zinc (His286, His323 and
Asn201) and the bridging ligand (Asp164) (red kidney
bean numbering) are conserved across all known
members of the PAP family [1]. Furthermore, substitu-
tion of zinc with FeII in the red kidney bean enzyme
active site generates a redox-active form of the enzyme
with spectroscopic properties similar to those of the mam-
malian enzymes [19]. A tentative model for the mam-
malian enzyme was developed on the basis of secondary
structure prediction and the crystal structure of the red
kidney bean enzyme [20].
The most abundant source of the mammalian enzyme is
pig allantoic fluid where the protein may have a novel
function in iron transport [21]. We now report the experi-
mentally determined three-dimensional structure of the
pig allantoic fluid enzyme (uteroferrin) at 1.55 Å resolu-
tion. The enzyme is comprised of two sandwiched
β sheets flanked by α-helical segments. The molecule
shows internal symmetry, with the metal ions bound at
the interface between the two halves. Despite less than
15% sequence identity, the protein fold resembles that of
the catalytic domain of plant PAP and of some
serine/threonine protein phosphatases.
Results and discussion
Structure of mammalian purple acid phosphatase
Previous studies in our laboratory showed that the addi-
tion of phosphate to reduced pig allantoic fluid purple acid
phosphatase (PPAP) led to rapid oxidation of the enzyme
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Table 1
Statistics for data collection and heavy-atom phasing.
Native* Native† K2Cl6Os K2PtCl4 K2Pt(NO)4 K2Pt(NO)4 K2Cl4Au HgCl2
Resolution (Å) 1.55 2.00 2.50 3.00 2.50 2.50 4.00 2.70
Resolution for outer shell (Å) 1.61–1.55 2.07–2.00 2.59–2.50 3.11–3.00 2.59–2.50 2.59–2.50 4.14–4.00 2.80–2.70
Total observations (I > 0σ(I)) 140,370 69,826 40,174 20,921 51,966 25,367 5479 16,104
Unique reflections (I > 0σ(I)) 46,161 24,836 12,179 7410 14,276 9047 2334 8978
Completeness (%) 89.4 96.4 91.9 94.7 96.0 68.6 68.9 82.1
Completeness for outer shell (%) 57.4 94.0 69.9 94.1 93.0 53.1 73.9 73.0
I/σ(I) 9.6 9.4 10.6 5.8 7.4 9.7 5.8 6.7
I/σ(I) for outer shell (%) 2.1 2.6 3.1 3.0 3.6 2.9 4.5 2.4
Rmerge (%)‡ 5.9 6.4 6.8 12.9 9.4 7.2 11.9 10.5
Rmerge for outer shell (%) 27.1 31.3 22.7 26.8 27.1 22.7 19.6 27.8
Soak time (days) 2 1 1 2 1 7
Soak concentration (mM) 33 3 3 33 3 33
Riso (%)§ 11.1 10.5 9.1 15.9 13.1 17.9
Maximum resolution for phasing (Å) 2.8 3.0 3.5 2.8 4.5 4.5
RCullis¶ 0.598 0.591 0.578 0.570 0.585 0.562
RKraut¥ 0.169 0.146 0.109 0.220 0.173 0.247
Phasing power** 1.40 1.37 1.33 1.56 1.45 1.52
FOM 0.268 0.311 0.322 0.287 0.301 0.283
Number of heavy-atom sites 4 4 3 6 7 5
Overall FOM 0.475
FOM after solvent flattening 0.809
*Native data collected at 100K. †Native data and all heavy-atom data
collected at room temperature. ‡Rmerge = ΣIi – < I > /ΣIi.
§Riso = ΣFPH – Fp/ΣFP.
¶RCullis = ΣIIIFPHobs±FPobs–FHlcalc/ΣIIFPHobs±FPcalc, where
FP, FPH and FH are the native structure factor, the protein and heavy-
atom structure factor, and the heavy-atom structure factor,
respectively. ¥RKraut = ΣFPHobs – FPcalc/ΣFPHobs. **Phasing
power = Σ < FH > /E, where < FH > is the rms heavy-atom structure
factor and E is the residual lack of closure. FOM, figure of merit.
and formation of a very stable oxidised enzyme–phos-
phate complex [22]. Crystals of this complex have been
grown by hanging-drop vapour diffusion and microseed-
ing. Native crystals, cryocooled to 100K, diffracted to
1.55 Å. Six heavy-atom derivatives (Table 1) were used to
solve the structure, which has an R factor of 0.213 and
Rfree of 0.257 (Table 2). The final model includes residues
3–304 of the 313-residue mature protein, two iron atoms,
the bridging oxygen atom, the bound phosphate, the first
two sugar residues of the single oligosaccharide linked to
Asn97, 339 water molecules and one isopropanol molecule
(Figure 1). An example of the quality of the final electron
density is shown in Figure 2.
The structure is approximately spherical with dimensions
of 45 × 45 × 40 Å. The core structure consists of two
mixed β sheets packed together in a β sandwich which is
flanked on either side by α-helical segments in a four-
layer αββα sandwich architecture. Loops connecting the
secondary structure elements provide all but one of the
sidechain ligands for the binuclear metal centre. A disul-
phide bond with a left-hand spiral conformation links
residues 142 and 200.
Figure 3 compares the three-dimensional structures of the
pig enzyme and the red kidney bean enzyme (RKPAP)
and provides a structure-based sequence alignment. As
predicted by Klabunde et al. [20] the core Cα structures
are very similar. The root mean square deviation (rmsd)
for Cα atoms of 204 core residues (shown in green in
Figure 3) is 1.4 Å. Apart from the N-terminal domain
(blue; Figure 3) which is absent in the mammalian
enzyme, there are three regions in which significant struc-
tural differences are observed (magenta; Figure 3): the
dimer interface of the plant enzyme; the surface of the
mammalian enzyme exposed by the absence of the N-ter-
minal domain; and variable loops in the vicinity of the
active site (see below).
Internal symmetry 
A striking feature of the PPAP structure is the pseudo-
twofold symmetry, with the binuclear metal centre located
on the twofold axis (Figure 4). A common structural motif
(purple elements in Figure 4) is present in each half (des-
ignated motifs A and B). This motif comprises a core
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Table 2
Refinement statistics.
Resolution range (Å) 100–1.55
Reflections F > 1σ(F)) 43,833
Protein atoms 2371
Carbohydrate atoms 28
Fe atoms 2
Solvent atoms 340
R factor (%)* 0.213
Rfree (%)* 0.257
Rmsd bond lengths (Å) 0.007
Rmsd bond angles (°) 1.31
Average B factor (Å2) 20.0
*R = ΣFobs–Fcalc/ΣFobs, where the R factor is calculated
based on the reflections used in the refinement (90% of the total data),
and Rfree [50] is calculated using the remaining 10% of the data.
Figure 1
Structure of pig purple acid phosphatase. (a) Schematic representation
of the oxidised pig purple acid phosphatase–phosphate complex,
showing the approximate twofold symmetry of the molecule. Helices are
drawn as blue cylinders and strands as yellow arrows. Turns and random
coils are shown in green. The Fe atoms are drawn as orange spheres
and the bridging oxygen as a red sphere. The disulphide bond (in the top
left corner), two carbohydrate residues N-linked to Asn97, and the
phosphate molecule is drawn in ball-and-stick representation.
(b) Stereoview Cα trace of pig purple acid phosphatase. The figure is in
the same orientation as (a). The Fe atoms are identified by spheres.
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Structure
βαβαβ unit forming a parallel β sheet, plus two additional
β strands, one on either side of the core β sheet. The Cα
atoms of the 56 residues from each of the two motifs can
be superimposed with an rmsd of 1.72 Å.
The finding of internal structural similarity in PAP sug-
gests that the enzyme may have evolved by gene amplifi-
cation. Motifs A and B were therefore analysed to identify
whether there is any residual sequence homology. The
only significant similarity is found in a short stretch of
sequence following the fourth β strand in the motif,
91-NHDH-94 (single-letter amino acid code) in motif A
and 220-GHDH-223 in motif B. This is nonetheless an
important similarity as both of these sequences contribute
two metal- or ligand-binding residues (in boldface type;
also see below). Furthermore, the topologically equivalent
loops between strand S2 and helix H2 of motif A (51-
GDNFYFTGVHDAK-63) and between strand S7 and
helix H7 of motif B (185-GHYPVWSIAEHGP-197) each
provide two metal- or ligand-binding residues. In this latter
case, ligand-binding function appears to be conserved
between the two motifs, but structural and sequence
homology is not significant. In the pig gene the majority of
the coding region is on a single exon, but in mouse and
human genes an intron after the Trp111 codon is close to
the boundary separating the two halves of the molecule
[23]. This observation supports the view that the two
halves constitute ‘genetic domains’ brought together
during evolution. In this structure each motif contributes
ligands to both metal ions, so that some exchange of
ligands between metal ions must also have occurred.
The symmetry within PPAP indicates the possibility of
symmetry in the RKPAP monomer. Indeed, in the paper
describing the structure of the plant enzyme it was noted
that the C-terminal domain incorporated two sandwiched
βαβαβ motifs forming the core unit of the enzyme [18].
However, the plant enzyme is more complex than mam-
malian PAP (see comparison of the two structures in
Figure 3) and the symmetry is less evident. Nevertheless,
it is possible to superimpose the Cα atoms of 51 residues
in the equivalent motifs A and B of the plant enzyme with
an rmsd of 1.82 Å. 
We speculate that there may be additional examples of
binuclear metal ion complexes in proteins which have
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Figure 2
Electron density at the active site of pig purple
acid phosphatase. (a) Stereoview of the
active site of the oxidised enzyme–phosphate
complex, showing the Fe atoms, bridging
oxygen, phosphate and metal-binding ligands.
The cis peptide bond can also be seen
between Tyr55 and Phe56. (b) Alternative
view of the active site rotated by 180° around
the y axis, as compared with (a), and with the
phosphate removed to highlight the bridging
oxygen and carboxylate groups. The 2Fo–2Fc
electron density, contoured at 2.0σ, is overlaid
in both images.
evolved by combining protein domains for mononuclear
complexes. An alternative pathway for the evolution of
such centres has been proposed for the enzyme urease,
which contains two nickel ions. The structure of the cat-
alytic domain of urease is very similar to that of the
mononuclear zinc enzyme adenosine deaminase. It has
been suggested on this basis that urease has evolved from
a single ancestral adenosine deaminase-like protein by
way of mutation to provide additional ligands such as the
bridging carbamylated lysine ligand [24]. Further analysis
of the structures of other binuclear metal-containing pro-
teins and their corresponding genes would allow comment
on the generality of these mechanisms.
Active-site structure and catalytic mechanism
The structure of the active site of the enzyme–phosphate
complex in the vicinity of the metal centre is shown in
Figure 2 and the important bond distances are shown in
Tables 3 and 4. The FeIII–FeIII distance is 3.31 Å, which is
consistent with that found by extended X-ray absorption fine
structure (EXAFS) studies (3.2–3.3 Å) [25,26] and the crystal
structure of RKPAP (3.26 Å). The coordination spheres of
both metals are close to octahedral. Phosphate bridges the
two metals symmetrically. Strong electron density is
observed for a bridging oxo/hydroxo group (Figure 2). The
bridging oxygen is within hydrogen-bonding distance of the
carbonyl oxygen of His221. In RKPAP the bridge could not
be unambiguously located from the electron density but was
modelled into a similar position to that found in the pig
enzyme [15]. The modelled hydroxo group was within
hydrogen-bonding distance of the carbonyl oxygen of
His323, equivalent to His221 in the pig enzyme. The obser-
vation of the bridging solvent molecule in the oxidised
enzyme–phosphate complex counters previous suggestions
Research Article  Mammalian purple acid phosphatase Guddat et al. 761
Figure 3
Comparison of pig and red kidney bean
purple acid phosphatases. (a) Structure-
based sequence alignment of red kidney bean
(RKB) and pig purple acid phosphatase. The
sequence of the human enzyme is also
included and is aligned with the pig enzyme
on the basis of sequence homology. Residues
in green were aligned using the LSQ features
in the program O [43]. Secondary structure
elements are indicated and labelled H for helix
and S for strand, and are shown above (pig)
and below (red kidney bean) the sequence,
respectively. These elements were defined
using the program DSSP [51]. Glycosylation
sites and metal-binding ligands are identified
by an asterisk and hash symbol, respectively.
The disulphide bond connecting residues 142
and 200 in the pig enzyme is depicted by a
dashed line. Ribbon diagrams are also shown
that compare the structures of (b) pig and
(c) red kidney bean purple acid
phosphatases. The Fe atoms are drawn as
orange spheres and the Zn atoms as silver
spheres. Disulphide bonds are in yellow. The
Cα atoms are colour-coded such that the N-
terminal domain in the red kidney bean
structure is in blue, structurally conserved or
‘core’ residues in the two enzymes are in
green, and the remaining residues are in
magenta. (The same colouring is used for the
sequence alignment above.) 
                              <S1>                  <H1>    <S2> 
                       1     6            17        25           38   41             55
                       |     |        #   |         |            |    |            # #
Pig                    TAPTP ILRFVAV GDWG G VPNAPFH TAREMANAKAIATT VK TLGADFILSL GDNFY FTG
Human                  ..ATP ALRFVAV GDWG G VPNAPFH TAREMANAKEIART VQ ILGADFILSL GDNFY FTG
RKB      121 residues  TGLDV PYTFGLI GDLG Q ....... SFDSNTTLSHYELS .. PKKGQTVLFV GDLSY ADR
                       |     |            |         |   *        |    |              |
                       122   127          138       139          152  153            167
                              <S1>                  <H1>           S2>        
                <H2>                 S3>    <H3>               <H4>        S4      <S5>
                    69  73         82             95             97   102            115     123
                    |   |          |         #    |              *    |              |       |
Pig      VHDAKDKRFQ ETFED VFSDPSLR NVPWHVL AGNH DHL G........... NVSAQI AYSKISKRWNFP SPYYRLRFK
Human    VQDINDKRFQ ETFED VFSDRSLR NVPWHVL AGNH DHL G........... NVSAQI AYSKISKRWNFP SPFYRLHFK
RKB      YPNHDNVRWD TWGRF TERSV..A YQPWIWT AGNH EIE FAPEINETEPFK PFSYRY HVPYEA.SQSTS PFWYSIKRA
                    |   |          |              |      *       |    |              |       |
                    181 185        192            205            218  223            235     243 
               <H2>  <H3>       S3                       <H4>                   <S4>
                <S 6>  <H5>                 <H6>          <S7>
                130        141                     163         175      179             193  
                |          |                       |           |        |       #  
Pig      IPRSNV SVAIFMLDTVTL CGNSDDFVSQQPERPRNLALA RTQLAWIKKQLAA AK...E DYVL VAGHYP VWSIA .
Human    IPQTNV SVAIFMLDTVTL CGNSDDFLSQQPERPRDVKLA RTQLSWLKKQLAA AR...E DYVL VAGHYP VWSIA .
RKB      ...... SAHIIVLSSHIA Y.................GRG TPQYTWLKKELRK VKRSET PWLI VLMHSP LYNSY N
                |          |                       |           |        |               |
                244        255                     260         272      279             293   
                 <S5>                               <H5>          <S6>
                <H7> <H8>   <S8>       <S9>                          <S10>   
                199                               231                    234      243
                |                      # #        |                      |        | 
Pig      EHGP.T HCLVKQLLPLLTTHKVTAYLC GHDH NLQYLQDE N..................G LGFVLSGAGN ...
Human    EHGP.T HCLVKQLRPLLATYGVTAYLC GHDH NLQYLQDE N..................G VGYVLSGAGN ...
RKB      HHFMEG EAMRTKFEAWFVKYKVDVVFA GHVH AYERSERV SNIAYKITDGLCTPVKDQSA PVYITIGDAG NYG       
                |                                 |                      |        |
                301                               333                    354      363
                <H6>     <S7>       <S8>  S9>             S10     <S11>
                           <S11>         <S12>       <S13>         <S14>
         244  249        258    265     271    278    282      291    293        304       313
         |    |          |      |       |      |      |        |      |          |         |
Pig      FMDPSK KHLRKVPN GYLRFHFG AENSL GGFAYVEI TPK. EMSVTYIEAS G... KSLFKTKLPRRA RSEHQHRRA      
Human    FMDPSK RHQRKVPN GYLRFHYG TEDSL GGFAYVEI SSK. EMTVTYIEAS G... KSLFKTRLPRRA RP.......
RKB      VIDSNM IQPQP... EYSAFREA S.... FGHGMFDI KNRT HAHFSWNRNQ DGVA VEADSVWFFNRH WYPVDDST.
         |    |          |      |       |      |  *   |        |      |          |        |
         367  372        378    385     387    394    399      408    413        424      432
                           <S12>         <S13>      <S14>         <S15>        
(a)
(b) (c)
Structure
that phosphate might displace the bridging solvent mol-
ecule upon binding to the enzyme [27]. The iron–oxygen
bond lengths and the Fe–O–Fe bond angle (2.08 Å, 105.7°)
are consistent with values determined for the oxidised pig
enzyme–phosphate complex by EXAFS (1.94 Å, 109°), and
are more consistent with a bridging hydroxo than an oxo
group based on a comparison with model oxo-bridged com-
plexes [28]. A range of other spectroscopic evidence sup-
ports this view (reviewed in [1]). 
A role for the bridging hydroxo group as the attacking
nucleophile in the hydrolytic mechanism of PAP and the
serine/threonine protein phosphatases has been suggested
[14,27], and is supported by 18O-labelling studies of a
model complex in which a phosphate ester is coordinated
to two Co(III) centres with bridging hydroxo groups [29].
Alternatively, Aquino et al. [30] have obtained kinetic data
which favour a mechanism in which monodentate binding
of phosphate esters to the divalent metal is followed by
762 Structure 1999, Vol 7 No 7
Figure 4
Internal symmetry in the pig purple acid
phosphatase structure. The pseudo-symmetry
in the pig purple acid phosphatase structure
is emphasised by depicting the secondary
structure elements of the two motifs in purple.
One half (left) incorporates residues from both
the N terminus (1–115) and the C terminus
(270–303) and the other half incorporates the
consecutive residues 116–269. Each half
comprises a seven-stranded mixed β sheet
flanked on one surface by α helices and
loops. The two loops that connect motifs A
and B are in green and other structural
elements are in yellow. The Fe atoms are
depicted as orange spheres and the bound
phosphate is shown in ball-and-stick
representation. (a) The structure of the pig
enzyme, with the pseudo-symmetry axis
aligned approximately in the direction of the y
axis. Shown below are the two halves of the
structure opened out like the pages of a book,
by rotating each half by 90° or –90° around
the y axis. (b) The topology of the pig enzyme,
again highlighting the pseudo-symmetry in the
structure. The purple secondary structure
elements within each motif are labelled as in
Figure 3. The approximate position of the
metal-binding ligands (red spheres) and the
bridging ligand (red square) are also shown.
H2    H1 H7   H6
S4      S3       S2  S1  S12
N              C
S10    S8      S7    S6   S5
Structure
Motif A Motif B
(b)
(a)
90º90º
attack by the hydroxide ligand coordinated to ferric ion.
Furthermore, they propose that bridging of the phosphate
ester between the metals results in a nonproductive
complex. In the serine/threonine protein phosphatases,
bidentate binding of the phosphate ester and a coordi-
nated hydroxyl group may both be accommodated in the
enzyme–substrate complex. However, in PAP, this coordi-
nated hydroxyl group is replaced by the tyrosine sidechain
responsible for the purple colour. Labelling of the bridg-
ing oxygen with 18O should in principle allow a distinction
between these mechanisms.
The spatial arrangement of the metal ligands in the pig
and red kidney bean enzymes is very similar (Figure 5).
The Cα atoms of the seven metal-binding residues super-
impose with an rmsd of 0.18 Å. Two other residues in the
vicinity of the metal centre, His92 and His195, which are
hydrogen bonded to phosphate, also occupy equivalent
positions in the two structures. As can be seen from
Figure 5, however, these are the only sidechains which
may be overlaid between the two proteins in the vicinity
of the binuclear centre. A significant difference is that a
third histidine (His295), which in the RKPAP interacts
with phosphate, is replaced by glutamic acid in PPAP
(Glu194) and is oriented away from the phosphate in the
oxidised enzyme–phosphate complex. A further point of
interest is that two of the metal-binding ligands are associ-
ated with unusual mainchain conformations: His221 (the
carbonyl oxygen of which is within hydrogen-bonding dis-
tance of the bridging hydroxyl) is part of a γ turn and
Tyr55 has a cis peptide bond to Phe56. The γ turn is also
present in RKPAP but there is no evidence for a cis
peptide bond (presumably because of the lower resolu-
tion). The polypeptide chain in this region of RKPAP
forms a 310 helix. These unusual conformations may be
stabilised by the geometric requirements of the metal ion
complex, and it will be interesting to see whether they are
retained in the apoenzyme structure.
There are significant differences between the pig and red
kidney bean enzymes beyond the immediate vicinity of
the metal ions. The most obvious difference (Figure 5) is
the loop (residues 142–159), which is an insert in the
PPAP sequence compared with that of RKPAP
(Figure 3). The loop is tethered to motif B through a
disulphide bond. It has long been known that some mam-
malian PAPs can be cleaved within this loop by trypsin or
α-chymotrypsin, yielding two disulphide-bonded frag-
ments. The nicked form of the bovine enzyme has a kcat
value approximately fivefold higher than that of the intact
enzyme for p-nitrophenyl phosphate, whereas the Km
values for the two forms are similar [31]. An increase in
specific activity of the human, mouse and pig enzymes is
also seen upon nicking [3,31]. As well as having an effect
on the catalytic efficiency, it seems likely that a loop in
this position could affect the specificity of the enzyme
towards high molecular weight substrates such as phos-
phoproteins. There is another loop in the corresponding
position in motif A (Figure 5; residues 18–24) which may
also be involved in substrate binding. Other polar
residues in the active-site region which have been tenta-
tively implicated in substrate binding in RKPAP [18] are
not conserved in PPAP. For example, Arg258 is replaced
by Leu161, Glu299 and Tyr365 are deleted, and His253
is replaced by Val139. Additional differences in the sub-
strate-binding sites of the two enzymes may exist if, as
has been suggested, residues on one monomer of the
dimeric RKPAP contribute to the active site on the
opposing monomer (e.g. Lys306) [15,18]. Overall, this
structural comparison shows that the specificities of these
enzymes, especially for large substrates, are likely to be
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Table 4
Selected active-site distances.
From To Distance (Å)
µ-oxo Asp52 Oδ2 2.90
His221 Nδ1 3.19
His223 Nε2 3.13
Asp14 Oδ2 2.77
PO4 O1 2.88
PO4 O3 2.68
PO4 O4 2.77
His221 C=O 2.46
PO4 O1 His195 Nε2 2.76
PO4 O2 His92 Nε2 2.68
PO4 O4 2.45
PO4 O3 His92 Nε2 3.17
Asp52 Oδ2 3.04
His223 Nε2 3.13
PO4 O4 Asn91 Nδ2 2.73
Table 3
Metal–ligand distances.
Metal ion Ligand atom Distance (Å)
FeIII* Asp14 Oδ2 2.11
Asp52 Oδ2 2.27
Tyr55 OH 1.98
His223 Nε2 2.32
µ-oxo O 2.08
PO4 O3 2.26
FeII*† Asp52 Oδ2 2.40
Asn91 Oδ1 2.24
His186 Nε2 2.23
His221 Nδ1 2.37
µ-oxo O 2.08
PO4 O4 2.45
*The Fe–O–Fe angle is 105.7°. †The Fe atom that is FeII in the active
form of the enzyme.
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Figure 5
Structural comparison of pig purple acid
phosphatase, red kidney bean purple acid
phosphatase and PPP-type serine/threonine
protein phosphatases. (a,b) Stereoview
diagrams showing the superimposition of pig
(yellow) and red kidney bean (blue) purple
acid phosphatases. (a) All-atom
superimposition of the region in the vicinity of
the active site. (b) Ribbon trace of the whole
of the pig purple acid phosphatase
superimposed onto the C-terminal domain of
the red kidney bean enzyme. The bridging
oxygen (red sphere) and Fe atoms (orange
spheres) are shown for the pig enzyme.
Phosphate is shown as a purple stick model
and residue numbers are labelled in purple
(pig) or blue (red kidney bean). Major
differences occur at loops 142–159 and
18–24, which are insertions in pig purple acid
phosphatase compared with the red kidney
bean enzyme. (c) Stereoview diagram
showing the superimposition of Cα atoms
from a core region of the structures of
mammalian purple acid phosphatase (purple),
protein phosphatase 1 (blue) [38] and
calcineurin (orange) [39]. The metal atoms are
drawn as CPK spheres. (d) Stereoview
diagram showing the superimposition of the
complete Cα trace of mammalian purple acid
phosphatase (purple) and protein
phosphatase 1 (blue).
quite different. Even for small substrates, differences in
substrate specificity have been observed between
RKPAP and PPAP. For example, RKPAP exhibits a
marked preference for ATP over p-nitrophenyl phos-
phate, whereas the reverse is the case for PPAP [32,33]. 
Both enzymes exhibit a strong preference for activated
versus unactivated phosphate esters, which distinguishes
them from the serine/threonine protein phosphatases. In
particular, we have shown that the pig and human PAPs
catalyse the hydrolysis of phosphotyrosine-containing
peptides very efficiently [3,34]. The difference might be
attributable to the ability of the serine/threonine phos-
phatase to protonate the leaving group of unactivated
substrates more effectively than does PAP. 
Comparison with other protein structures
In the CATH classification system, proteins are grouped
according to class, architecture, topology and homologous
superfamily [35] (http://www.biochem.ucl.ac.uk/bsm/cath).
PPAP is in the α/β class of proteins that have a four-layer
αββα sandwich architecture. Within this architecture, six
different CATH topologies have been described. The
C-terminal domain of RKPAP corresponds to one of these.
As described above, the pig enzyme has the same topol-
ogy as the RKPAP catalytic domain. Furthermore, their
sequence homology also groups them within the same
homologous superfamily. The other five CATH topolo-
gies of the four-layer αββα sandwich architecture are note
worthy because they all bind two or more metal ions: the
serine/threonine phosphatases, such as protein phos-
phatase 1 and protein phosphatase 2B (calcineurin); alde-
hyde ferredoxin oxidoreductase; deoxyribonuclease I;
metallo-β-lactamase; and glutamine phosphoribosylpy-
rophosphate amidotransferase.
The similarity between RKPAP and the serine/threonine
protein phosphatases of the PPP gene family has been
noted previously. Indeed, in the SCOP protein classifica-
tion scheme [36] (http://scop.mrc-lmb.cam.ac.uk/scop/),
these two protein classes are grouped within the same
superfamily and within the same fold. This definition for
the ‘metallo-dependent phosphatase’ fold would also
encompass the structure of protein phosphatase 2C, a PPM-
type metal-dependent serine/threonine protein phos-
phatase. However, the PPM topology is clearly different
from the PPP topology and is suggestive of convergent evo-
lution [37], whereas the topologies of PAPs and the PPP
phosphatases are very similar. The Cα atoms of 102
residues of PPAP can be superimposed onto the structure
of protein phosphatase 1 (PDB accession code 1fjm [38])
with an rmsd of 1.9 Å (Figure 5). There is, however, little
structural similarity outside this region (Figure 5). The Cα
atoms of 111 residues of PPAP can also be superimposed
onto the structure of calcineurin (PDB accession code 1aui
[39]) with an rmsd of 2.1 Å. Furthermore, the PPP fold has
just two cross-overs between the two halves of the phos-
phatase domain, and these are at exactly the same points in
the topology as the two cross-overs of PAP. By comparison,
the PPM fold has four cross-over points between the two
halves. Finally, as noted earlier, there is a conserved
sequence motif spanning the metal ligands in the PPP and
PAP families, which is not present in the PPM family. It has
been suggested that this conserved sequence motif indi-
cates divergent evolution from an ancestral metallophos-
phoesterase [14]. Mammalian PAP, with its simple
single-domain structure and striking internal pseudo-sym-
metry, may more closely resemble an ancestral metal-
lophosphoesterase than the multidomain PPP phosphatases
and the multidomain dimeric RKPAP. Furthermore, the
internal symmetry of the mammalian PAP suggests that an
ancestral metallophosphoesterase could, in turn, have
evolved from a gene amplification event from a metal-
binding (or phosphate-binding) protein, possibly having a
two-layer αβ sandwich architecture. It will be interesting to
see if any proteins that have this simpler architecture are
known to bind metal and/or phosphate. 
Comparison of pig and human PAPs
As noted earlier, one impetus to solving the structure of
mammalian PAP is the potential for structure-based
design of active-site antagonists of the human enzyme in
osteoclasts. The sequences of human and pig enzymes are
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Figure 6
CPK representation of the surface of pig purple acid phosphatase.
White atoms are identical to those in the human enzyme. Residues
coloured blue represent conservative changes in the human enzyme
and those in red are not conserved (see also Figure 3). The Fe atoms
are shown as orange spheres and the phosphate is drawn in magenta. 
Structure
~88% identical with 36 amino acid differences, only seven
of which are not conservative. A preliminary homology
model of the human enzyme, constructed from PPAP,
shows that 29 of the 36 different residues are exposed to
the surface and seven are buried. Figure 6 shows a CPK
model of the PPAP structure with differences between
the enzymes highlighted. It is evident that few of the
changes are near the active site. In summary, the pig
enzyme structure is a good model for human PAP.
Biological implications
Mammalian purple acid phosphatases, or tartrate-resis-
tant acid phosphatases, are expressed by osteoclasts, the
cells that resorb bone, and by activated macrophages.
There is strong evidence that the osteoclast enzyme is
required for normal bone resorption, and elevated serum
levels are associated with osteoporosis and other meta-
bolic bone diseases and malignancies. Mammalian purple
acid phosphatase has therefore been identified as a possi-
ble target for antiosteoporotic drugs. The high-resolution
crystal structure of the pig enzyme provides a basis for
the structure-based design of such compounds.
Mammalian purple acid phosphatase catalyses two
diverse reactions: the hydrolysis of phosphate esters
(including phosphoproteins) and the production of
hydroxyl radicals. The significance of the phosphatase
activity and hydroxyl radical production in the function
of osteoclasts and macrophages is not known. The mam-
malian enzyme has a similar protein fold and binuclear
metal-binding site to that of the plant enzyme (and to the
catalytic domain of PPP-type serine/threonine phos-
phatases), suggesting similar catalytic mechanisms.
However, the mammalian and plant sequences are only
~15% identical and the plant enzyme has an N-terminal
domain that is absent in the mammalian enzyme. In
addition, the mammalian enzyme is monomeric and the
plant enzyme is dimeric. Of most importance, the protein
architectures surrounding the active sites of the two
enzymes are significantly different. These differences
suggest that the substrate(s) and function(s) of the mam-
malian and plant enzymes are likely to be quite distinct. 
The structure of pig purple acid phosphatase exhibits
striking internal symmetry that was not apparent in the
more complex plant enzyme and PPP-type phosphatase
structures. The symmetry suggests that the binuclear
metal centre evolved through the combination of single
metal-binding centres. We postulate that this might rep-
resent a general mechanism for the evolution of binu-
clear metal-containing proteins.
Materials and methods
Crystallisation 
Pig allantoic fluid purple acid phosphatase (PPAP) was purified as
described previously [6] and the oxidised enzyme–phosphate complex
prepared as described [22]. The oxidised enzyme–phosphate complex
was crystallised by the hanging-drop method. The well solution for
crystallisation consisted of 0.1 M sodium citrate pH 5.0, 25% (w/v)
PEG 3300, 0.1 M LiCl and 10% (v/v) isopropanol. A detailed descrip-
tion of the crystallisation will be published elsewhere. Native cryo-
cooled crystals diffracted strongly, allowing a data set to 1.55 Å
resolution to be collected. Cryocooling did not always yield isomor-
phous crystals of the native enzyme; therefore the search for heavy-
atom derivatives was carried out at room temperature. However, at
room temperature, crystals were stable for only 18 h in the X-ray beam,
resulting in data sets of 2.0 Å resolution or less. 
Data collection and structure determination
Crystals belonged to the space group P212121 and had one molecule
per asymmetric unit and the cryocooled crystal had a unit cell of
a = 64.61 Å, b = 70.01 Å, c = 77.11 Å, α = 90.0°, β = 90.0° and
γ = 90.0°. Room temperature crystals had a slightly larger unit cell of
a = 66.85 Å, b = 70.12 Å, c = 78.52 Å, α = 90.0°, β = 90.0° and
γ = 90.0°. All X-ray data were measured on an R-Axis IIC area detector
and processed using DENZO and Scalepack [40]. Heavy-atom posi-
tions for four of the derivatives were found independently by direct
methods using SHELXS [41]. Difference Fourier techniques were used
to identify metal-binding sites for the gold and mercury derivatives and
additional heavy-atom sites for the first four derivatives. Heavy-atom
positions and occupancies were refined using the PHASES program
package [42]. MIR phases were improved by solvent flattening using
BC Wang’s procedure as implemented in PHASES. The program O
[43] was used for model building and inspection of electron-density
maps. The highest features in the experimental map were attributed to
the Fe–Fe dimetal centre and phosphate. With this information a Cα
trace of the RKPAP crystal structure was overlaid onto the PPAP elec-
tron density. This established the hand of the molecule and facilitated
the tracing of ~85% of the polypeptide chain. At that point, data from
the cryocooled crystal (1.55 Å resolution) were used to construct
2Fo–Fc and Fo–Fc electron-density maps. Multiple stages of model
building and crystallographic refinement, with a bulk-solvent correction,
were carried out using X-PLOR Version 3.851 [44], resulting in a final
model that included residues 3–304, two Fe atoms, the bridging
oxygen, bound phosphate, two N-acetylglucosamine residues, 339
water molecules and one isopropanol molecule. The electron density
for the sidechains of Lys109, Arg155, Lys177 and Arg253 was weak
and they were therefore modelled as alanine in the final structure.
Sidechains for Val12, Thr25, His199, Glu282 and Thr298 were mod-
elled in two alternate conformations. The final Rfree and R factor were
0.257 and 0.213, respectively. A Ramachandran plot was derived
using PROCHECK [45] and showed all but one residue, His221, in the
most favoured or allowed regions. This residue, which interacts with
the binuclear metal centre, is part of a classic γ turn. Two residues,
Pro21 and Phe56, have cis peptide conformations.
Figures for this paper were generated using MOLSCRIPT version
2.0.1 [46], RASTER 3D version 2 [47,48], SETOR [49], INSIGHT
97 (MSI Corporation) and IRIS SHOWCASE version 3.1 (Silicon
Graphics Corporation). 
Accession numbers
The refined coordinates and structure factors have been deposited in
the Brookhaven Protein Data Bank, are on hold for six months, and
have the accession codes 1ute and r1utesf, respectively.  
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